Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: Evaluation of the Toxicity and Quality of Life

NCT02281149 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT02281149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02281149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: Evaluation of the Toxicity and Quality of Life
Lead sponsor
Centre Oscar Lambret
Phase
Observational
Overall status
Completed
Start date
November 18, 2014
Completion date
March 31, 2026
Enrollment
500 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer